Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Receivables (2016 - 2025)

Historic Receivables for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to $32.4 million.

  • Lemaitre Vascular's Receivables rose 45.55% to $32.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.4 million, marking a year-over-year increase of 45.55%. This contributed to the annual value of $30.1 million for FY2024, which is 1994.49% up from last year.
  • As of Q3 2025, Lemaitre Vascular's Receivables stood at $32.4 million, which was up 45.55% from $36.5 million recorded in Q2 2025.
  • Lemaitre Vascular's 5-year Receivables high stood at $36.5 million for Q2 2025, and its period low was $19.5 million during Q3 2021.
  • For the 5-year period, Lemaitre Vascular's Receivables averaged around $26.0 million, with its median value being $25.1 million (2023).
  • Its Receivables has fluctuated over the past 5 years, first plummeted by 63.18% in 2021, then skyrocketed by 3511.85% in 2024.
  • Quarter analysis of 5 years shows Lemaitre Vascular's Receivables stood at $19.6 million in 2021, then increased by 12.27% to $22.0 million in 2022, then increased by 13.72% to $25.1 million in 2023, then rose by 19.94% to $30.1 million in 2024, then rose by 7.83% to $32.4 million in 2025.
  • Its last three reported values are $32.4 million in Q3 2025, $36.5 million for Q2 2025, and $35.1 million during Q1 2025.